The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.
2.1 billion cubic meters (brine volume) grading from 71.6 to 216.3 parts per million lithium (1.7Million Tonnes Lithium Carbonate Equivalent “LCE” high case)****; 2.1 billion cubic meters (brine ...